Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model

• Miriam Nörder,

  Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany

  ⨯
• Pablo D. Becker,

  Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany

  ⨯
• Ingo Drexler,

  Affiliation Institute of Virology, Technische Universität München and Helmholtz Centre Munich, Munich, Germany

  ⨯
• Claudia Link,

  Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany

  ⨯
• Volker Erfle,

  Affiliations Institute of Virology, Technische Universität München and Helmholtz Centre Munich, Munich, Germany, Clinical Cooperation Group Antigen Specific Immunomodulation, Technische Universität München and Helmholtz Centre Munich, Munich, Germany

  ⨯
• Carlos A. Guzmán

  * E-mail: carlos.guzman@helmholtz-hzi.de

  Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany

  ⨯